Search Results for: cryo-cell

Recommended reads: stem cell scientists, eggs from blood, Cryo-Cell

Nobel Laureate Shinya Yamanaka, the first to produce induced pluripotent stem cells

We’ll begin this week’s recommended reads with some news on two wonderful stem cell scientists. While there are thousands of stem cell scientists, some stand out for their especially creative work. News on stem cell scientists   Nobel laureate Yamanaka to retire as director of iPS cell center, Asahi Shimbun. Dr. Yamanaka will spend more time …

Recommended reads: stem cell scientists, eggs from blood, Cryo-Cell Read More »

Therapeutic misconception & the planned Duke Cryo-Cell cord clinic

Duke Cryo-Cell therapeutic misconception

One of the core problems in the world of unproven stem cell clinics is something called therapeutic misconception. I’ll talk more about that in a minute, but first, let me tell you what brought this to mind now. Surprisingly, the story starts at Duke University. A Duke cell therapy team and the biotech Cryo-Cell have big …

Therapeutic misconception & the planned Duke Cryo-Cell cord clinic Read More »

Vice tackles dicey Cryo-Cell Duke mega-million peds clinic plan

Cord-blood-autism, Cryo Cell

When I first learned about the multi-$10 million cord cell clinic deal between Duke and Cryo-Cell I couldn’t believe what I was reading. Duke’s involved in this? The problem: marketing unproven cells for kids Yes, this wasn’t some stem cell clinic operating out of a strip mall seeking to make big money off of injecting …

Vice tackles dicey Cryo-Cell Duke mega-million peds clinic plan Read More »

FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it

cryo cell infusion clinic marketing

I recently found concerning SEC filings from the biotech Cryo-Cell about a deal it has with a Duke team for infusions of children with unproven umbilical cord cells. This turns out to be a $58 million deal. It relates in a major way to a Duke compassionate use or expanded access program (EAP) that already had raised …

FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it Read More »

Duke & Cryo-Cell plan big clinic for unproven infusions of kids

cryo cell duke stem cells autism cp

Professor Joanne Kurtzberg’s clinical work at the Duke Autism Center on umbilical cord blood for autism and cerebral palsy (CP) involves a partnership with a publicly-traded cord blood banking firm called Cryo-Cell. Kurtzberg is also the Medical Director at the firm. In addition they have intellectual property in this area. The Duke team’s efforts, including …

Duke & Cryo-Cell plan big clinic for unproven infusions of kids Read More »

Review of cord banker Viacord: dubious autism claims & other concerns

Viacord is one of the most well known firms in the for-profit cord blood banking industry. Today’s post is a review of the firm. I see concrete reasons for concern. What is Viacord? | Dubious autism claims | Viacord cost | Overall Review | References What is Viacord? As a cord blood banking firm, Viacord freezes …

Review of cord banker Viacord: dubious autism claims & other concerns Read More »

Cryo Cell reviews: dubious cord cell clinic plans, risks, other issues

Cryo Cell, Cryo-Cell

In today’s post I review the cord blood firm Cryo Cell International and discuss specific concerns I have about it. A major issue is their plan to open a clinic selling unproven cord cell infusions to kids. I believe this is risky both for the firm and more importantly for the children. What is Cryo …

Cryo Cell reviews: dubious cord cell clinic plans, risks, other issues Read More »

16 predictions for stem cells & regenerative medicine in 2022

regenerative medicine, stem cells 2021

The last few years in the stem cell and regenerative medicine arena have been complicated in many ways. Variables like surging stem cell clinics and COVID have made predictions harder.  Even so, trying to make predictions is useful and it’s fun to go over past year’s predictions. You can see my scorecard on my 2021 …

16 predictions for stem cells & regenerative medicine in 2022 Read More »

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court

regenerative medicine, stem cells 2021

The past year was all over the place for the stem cell and regenerative medicine field. As you can see in my scoring of my 21 predictions for 2021, quite a few things were surprises in terms of what did and didn’t happen. Here’s an overview of the top stories of the year in our …

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court Read More »

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best

Mesoblast stock

A quick review of the publicly-traded stem cell stocks I’ve been following in 2021 finds mostly discouraging news, but a few firms relatively outperformed the other publically-traded biotechs. One had some great news today. In this post, I’m doing a brief overview of how things went this year in the regenerative medicine space. I’m going …

2021 scorecard for stem cell stocks: REGN, VCEL, CCEL, LCTX did best Read More »